Clinical Trial Update: Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-A [Phase 3]

View source ↗

Summary

Phase 3 trial update suggesting integrated management enhances functional gains in children with cerebral palsy treated with botulinum toxin A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• BoNT-A

Snippet

Sponsor: Kocaeli University | Conditions: Cerebral Palsy | Phase 3 | Status: COMPLETED